Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L)’s Pliant Therapeutics PLRX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PLRX Stock Details PLRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$36K	Buy
2024 Q4	–	Sell
2024 Q3	$388K	Buy
2023 Q2	–	Sell
2023 Q1	$1.16M	Buy